Out-of-specification tisagenlecleucel does not compromise safety or efficacy in pediatric acute lymphoblastic leukemia
Jenna Rossoff, Christina Baggott, Snehit Prabhu, Holly Pacenta, Christine L. Phillips, Heather E. Stefanski, Julie-An Talano, Amy Moskop, Steven Margossian, Michael R. Verneris, Gary Douglas Myers, Nicole Karras, Patrick A. Brown, Muna Qayed, Michelle L. Hermiston, Prakash Satwani, Christa Krupski, Amy K. Keating, Rachel Wilcox, Cara A. Rabik, Vanessa A. Fabrizio, Michael Kunicki, Vasant Chinnabhandar, A. Yasemin Goksenin, Kevin J. Curran, Crystal L. Mackall, Theodore W. Laetsch, Liora M. Schultz
Topics & Concepts
MedicineBlinatumomabLymphoblastic LeukemiaAcute lymphocytic leukemiaLeukemiaIntensive care medicineImmunologyCAR-T cell therapy researchVirus-based gene therapy researchImmune Cell Function and Interaction